ES2091204T3 - Metodo y composiciones para conservar soluciones oftalmicas. - Google Patents

Metodo y composiciones para conservar soluciones oftalmicas.

Info

Publication number
ES2091204T3
ES2091204T3 ES89810578T ES89810578T ES2091204T3 ES 2091204 T3 ES2091204 T3 ES 2091204T3 ES 89810578 T ES89810578 T ES 89810578T ES 89810578 T ES89810578 T ES 89810578T ES 2091204 T3 ES2091204 T3 ES 2091204T3
Authority
ES
Spain
Prior art keywords
compositions
ophthalmic solutions
weight approximately
preserve ophthalmic
preserve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810578T
Other languages
English (en)
Inventor
Stephen M Martin
Fu-Pao Tsao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2091204T3 publication Critical patent/ES2091204T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124—Hydrogen peroxide; Peroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PROPORCIONA UN CONSERVANTE PARA DISOLUCIONES OFTALMICAS, QUE TIENEN UN INGREDIENTE ACTIVO, CON UN CONTENIDO EN PEROXIDO DE HIDROGENO DE 0,001-0,1 % EN PESO APROXIMADAMENTE, Y DIETILENTRIAMINA PENTA(ACIDO METILEN FOSFONICO), O UNA DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, PRESENTE A 0,002-0,03 % EN PESO APROXIMADAMENTE, Y/O 0,005-0,20 % EN PESO APROXIMADAMENTE DE ACIDO 1-HIDROXIETILIDEN-1,1-DIFOSFONICO, O UNA DE SUS SALES FISIOLOGICAMENTE COMPATIBLES.
ES89810578T 1988-08-04 1989-07-27 Metodo y composiciones para conservar soluciones oftalmicas. Expired - Lifetime ES2091204T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22916388A 1988-08-04 1988-08-04

Publications (1)

Publication Number Publication Date
ES2091204T3 true ES2091204T3 (es) 1996-11-01

Family

ID=22860073

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810578T Expired - Lifetime ES2091204T3 (es) 1988-08-04 1989-07-27 Metodo y composiciones para conservar soluciones oftalmicas.

Country Status (26)

Country Link
EP (2) EP0706802B1 (es)
JP (1) JP2915008B2 (es)
KR (1) KR100193585B1 (es)
AR (1) AR243374A1 (es)
AT (2) ATE141803T1 (es)
AU (1) AU628835B2 (es)
CA (1) CA1339031C (es)
DE (2) DE68929516T2 (es)
DK (2) DK175513B1 (es)
ES (1) ES2091204T3 (es)
FI (2) FI98334C (es)
GR (1) GR3020899T3 (es)
HK (1) HK1002991A1 (es)
HR (1) HRP940515A2 (es)
IE (2) IE960417L (es)
IL (1) IL91131A (es)
IN (1) IN170160B (es)
MX (1) MX174097B (es)
NO (2) NO177626C (es)
NZ (1) NZ230175A (es)
PH (1) PH27399A (es)
PT (1) PT91349B (es)
SG (1) SG64856A1 (es)
SI (1) SI8911541A (es)
YU (1) YU154189A (es)
ZA (1) ZA895932B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177481C (no) * 1991-09-10 1995-09-27 Hydrotec Norge Fremgangsmåte og anordning til desinfisering av råmaterialer, produkter og produksjonsutstyr
GB9122048D0 (en) * 1991-10-17 1991-11-27 Interox Chemicals Ltd Compositions and uses thereof
US5611464A (en) * 1995-05-30 1997-03-18 Ciba Geigy Corporation Container for preserving media in the tip of a solution dispenser
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
JPH09206362A (ja) * 1996-02-05 1997-08-12 Tomey Technol Corp コンタクトレンズ用消毒洗浄組成物及びそれを用いたコンタクトレンズの消毒洗浄方法
FR2751634B1 (fr) * 1996-07-29 1998-09-11 Essilor Int Solution stabilisee et tamponnee de peroxyde d'hydrogene, son procede de fabrication et son utilisation a la decontamination de lentilles de contact
GB2323180A (en) * 1997-01-23 1998-09-16 Waverley Pharma Ltd Hydrogen peroxide contact lens solution
JP2011042682A (ja) * 1997-05-20 2011-03-03 Senju Pharmaceut Co Ltd 水性製剤の増粘剤
JPH1143446A (ja) * 1997-05-20 1999-02-16 Senju Pharmaceut Co Ltd 水性製剤の増粘剤
CA2434961C (en) * 2000-11-08 2010-05-25 Bio-Concept Laboratories L-histidine in ophthalmic solutions
PE20030729A1 (es) * 2002-01-18 2003-10-21 Novartis Ag Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas
US20070048388A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070048389A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
KR20150017002A (ko) * 2006-03-17 2015-02-13 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 눈용 조성물
US9481856B2 (en) 2008-06-09 2016-11-01 Bausch & Lomb Incorporated Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide
TW201127423A (en) * 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1382466A (en) * 1971-04-30 1975-01-29 Allergan Pharma Germicide
US4304762A (en) * 1978-09-27 1981-12-08 Lever Brothers Company Stabilization of hydrogen peroxide
EP0265381B1 (en) * 1986-10-14 1991-05-29 Ciba-Geigy Ag A method of disinfecting soft contact lenses with a stabilized hydrogen peroxide solution
US4812173A (en) * 1987-05-01 1989-03-14 Ciba-Geigy Corporation Stabilized hydrogen peroxide contact lens disinfecting solution

Also Published As

Publication number Publication date
FI961336A (fi) 1996-03-22
IE892517L (en) 1990-02-04
DE68929516D1 (de) 2004-04-29
SI8911541A (en) 1997-10-31
EP0706802A2 (en) 1996-04-17
NO177626C (no) 1995-10-25
PH27399A (en) 1993-06-21
DE68927030D1 (de) 1996-10-02
DK381689D0 (da) 1989-08-03
SG64856A1 (en) 1999-05-25
PT91349A (pt) 1990-03-08
EP0354186A1 (en) 1990-02-07
FI106363B (fi) 2001-01-31
ATE141803T1 (de) 1996-09-15
NZ230175A (en) 1991-09-25
AU628835B2 (en) 1992-09-24
FI98334B (fi) 1997-02-28
DK175513B1 (da) 2004-11-15
GR3020899T3 (en) 1996-11-30
IN170160B (es) 1992-02-15
IL91131A0 (en) 1990-03-19
CA1339031C (en) 1997-04-01
EP0706802A3 (en) 1997-01-22
NO950227D0 (no) 1995-01-20
FI893661A0 (fi) 1989-08-02
DE68929516T2 (de) 2005-01-05
ZA895932B (en) 1990-03-28
KR900002789A (ko) 1990-03-23
IE81140B1 (en) 2000-04-05
YU154189A (en) 1990-12-31
AR243374A1 (es) 1993-08-31
DK175864B1 (da) 2005-04-18
NO893142L (no) 1990-02-05
FI961336A0 (fi) 1996-03-22
IE960417L (en) 1990-02-04
HRP940515A2 (en) 1996-06-30
FI893661A (fi) 1990-02-05
NO950227L (no) 1990-02-05
FI98334C (fi) 1997-06-10
EP0354186B1 (en) 1996-08-28
DE68927030T2 (de) 1997-02-27
ATE262354T1 (de) 2004-04-15
NO307500B1 (no) 2000-04-17
JP2915008B2 (ja) 1999-07-05
KR100193585B1 (ko) 1999-06-15
JPH0296531A (ja) 1990-04-09
IL91131A (en) 1993-06-10
PT91349B (pt) 1995-05-04
NO177626B (no) 1995-07-17
NO893142D0 (no) 1989-08-03
HK1002991A1 (en) 1998-09-30
AU3930389A (en) 1990-02-08
DK381689A (da) 1990-02-05
EP0706802B1 (en) 2004-03-24
DK200401093A (da) 2004-07-09
MX174097B (es) 1994-04-21

Similar Documents

Publication Publication Date Title
ES2091204T3 (es) Metodo y composiciones para conservar soluciones oftalmicas.
Erecińska et al. Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies
ES2041794T3 (es) Composicion aromatica vinilica estabilizada.
Pastorino et al. Ca2+ depletion prevents anoxic death of hepatocytes by inhibiting mitochondrial permeability transition
Quaife et al. Mechanisms of reoxygenation injury in cultured ventricular myocytes.
ZOCCARATO et al. Correlated effluxes of adenine nucleotides, Mg2+ and Ca2+ induced in rat‐liver mitochondria by external Ca2+ and phosphate
Broderick et al. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart
TR199700574T1 (xx) Molek�ler �aperon �retiminin haz�rlanmas� i�in yararl� hidroksilamin t�revleri ve bu t�revlerin haz�rlanmas�.
Schini et al. Effects of indapamide on endothelium-dependent relaxations in isolated canine femoral arteries
SE8603582D0 (sv) Komposition innehallande l-dopa
Williamson Control of energy metabolism in hamster brown adipose tissue
Lomneth et al. The role of transmembrane pH gradients in the lactic acid induced swelling of astrocytes
Schafer et al. Inhibition of NHE protects reoxygenated cardiomyocytes independently of anoxic Ca2+ overload and acidosis
Oviasu et al. Hormonal control of pyruvate dehydrogenase activity in rat liver
DK0693926T3 (da) Ny farmaceutisk sammensætning til fremstilling af et stabilt pulver indeholdende en kombination af acetylsalicylsyre og metoclopramid som aktiv bestanddel.
Ponce-Hornos et al. Effects of inorganic phosphate on ion exchange, energy state, and contraction in mammalian heart
Pomerantz et al. Sex and hormonal modification of 6-keto-PGF1α release by rat aorta
Hockwin Early changes of lens metabolism after X-irradiation
Taurog et al. Effects of hypophysectomy on organic iodine formation in rat thyroids
Åkerman Inhibition and stimulation of respiration-linked Mg 2+ efflux in rat heart mitochondria
Potter et al. Taurodeoxycholate and the developing rabbit distal colon: absence of secretory effect
Cornford Influence of mating on surface nutrient exchange in schistosomes
ES8504434A1 (es) Procedimiento para preparar una composicion fungicida a base de una sal de acido alquil-fosforoso
Watson et al. Diphenylhydantoin effects on salivary secretion and microsomal calcium accumulation and release
Boeynaems et al. Inhibition by iodide of the cholinergic stimulation of prostaglandin synthesis in dog thyroid

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354186

Country of ref document: ES